PFSA — Profusa, Inc.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1859807 ·
Last close
$2.18
Market Cap
$1.32M
52W High
$3000.00
52W Low
$1.58
ADV30
5,202,966
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -2,545,000 | -8,755,000 | 1,042,000 | 719,000 | 28,169,000 |
| Mar 2026 | 0 | — | -4,006,000 | -3,456,000 | 862,000 | 375,000 | 29,060,000 |
| Dec 2025 | 0 | — | -3,570,000 | -8,567,000 | 3,775,000 | 1,778,000 | 30,433,000 |
| Sep 2025 | 0 | — | -21,709,000 | -22,192,000 | 4,250,000 | 3,009,000 | 38,210,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-18,287,000
Investing CF
$-863,000
Financing CF
$19,506,000
CapEx
$-5,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1987.81
As of
2026-08-23
Balance + Analyst (yfinance extras)
Retained Earnings
$-164,237,000
Inventory
—
Receivables
$0
ST Investments
—
EBIT TTM
$-34,970,084
Pretax Income TTM
$-42,409,490
Interest Exp TTM
$1,347,000
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -27,706,000 | -35,823,000 | 3,775,000 | 30,433,000 | -26,658,000 | -16,248,000 |
| Dec 2024 | 0 | -4,500,000 | -9,230,000 | 3,073,000 | 122,278,000 | -119,205,000 | -2,066,000 |
| Dec 2023 | 0 | -6,070,000 | -10,281,000 | 1,893,000 | 111,889,000 | -109,996,000 | -4,402,000 |
| Dec 2022 | 0 | -9,443,000 | -20,217,000 | 1,031,000 | 100,802,000 | -99,771,000 | -7,702,000 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BBLG | Bone Biologics Corp | $1.37M | $0.50 | — |
| ESMC | ESCALON MEDICAL CORP | $1.26M | $0.17 | — |
| BTCY | BIOTRICITY INC. | $1.39M | $0.07 | — |
| NUMD | Nu-Med Plus, Inc. | $1.22M | $0.01 | — |
| GCTK | Glucotrack, Inc. | $1.45M | $1.82 | — |
News headlines (Yahoo Finance, 1h cache)
Profusa ISO 13485 Certification Decision Advances Lumee Oxygen Platform Toward CE Mark
2026-09-24 15:01 · Yahoo
Profusa, Inc. Receives Nasdaq Compliance Determination
2026-09-15 10:00 · Yahoo
Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement
2026-08-31 12:50 · Yahoo
Profusa Advances G3 Vision Labs Acquisition Conditions as Q2 Net Loss Widens
2026-08-20 14:49 · Yahoo
Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company
2026-08-20 12:30 · Yahoo
Profusa vies for potential G3 Vision Labs acquisition
2026-08-03 11:17 · Yahoo
Profusa Signs Term Sheet for Diagnostics Acquisition and Announces Leadership Changes
2026-07-27 14:38 · Yahoo
Profusa Announces Key Management Changes and Signing of Non-Binding Term Sheet for the Acquisition of a Commercial Stage Diagnostics Company
2026-07-27 10:00 · Yahoo
Profusa Announces 1-for-25 Reverse Stock Split
2026-07-02 15:00 · Yahoo
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
2026-06-24 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.